In vitro Diagnostics Market Analysis by Products (Instruments, Reagents), by Technology (Immunoassay, Clinical Chemistry, Microbiology), by Application (Oncology, Infectious Diseases, Nephrology, Diabetes, Cardiology), by End user, and by Region - Forecast to 2029

The global in vitro diagnostics market size is estimated to be USD xx billion in 2021 and is anticipated to witness a CAGR of xx% during the forecast period. Increase in global geriatric population is a key driver for the growth of the global in vitro diagnostics market. Additionally, rise in cases of chronic and infectious diseases and growth in awareness regarding diagnosis of disease in developing economies in the in vitro diagnostics market are some of the other drivers propelling the market growth. Nevertheless, unfavourable repayment situation and operative obstacles encountered in conducting diagnostic tests in the developed economies are expected to restrain the global market growth.

Global In vitro Diagnostics Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into instruments, reagents, and services. In 2021, the reagents segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in demand for devices that provide rapid and accurate diagnosis worldwide. Services segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the growing adoption of in vitro diagnostic systems along with analyser software at diagnostic centres and hospitals.

By Technology

Based on technology, the market is categorized into immunoassay, haematology, clinical chemistry, molecular diagnostics, coagulation, microbiology, and others. In 2021, the immunoassay segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to application of immunoassay in detection of infectious microbes, namely fungus, bacteria, and viruses, by finding their toxins worldwide. The microbiology segment is anticipated to grow at a profitable CAGR during the forecast period, due to the growing initiatives by administrations to develop patient outcomes using cost-effective and rapid diagnostic methods.

By Application

Based on application, the market is categorized into oncology, infectious diseases, nephrology, diabetes, cardiology, autoimmune diseases, drug testing, and others. In 2021, the infectious diseases segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to growing cases of infectious diseases such as HIV, SARS-CoV-2, AIDS, tuberculosis, and pneumonia worldwide. The cardiology segment is anticipated to grow at a profitable CAGR during the forecast period, due the high rate of penetration of PoC devices for rapid and on-site diagnosis in developed regions.

By End User

Based on end user, the market is categorized into home care, laboratory, hospitals, and others. In 2021, the hospitals segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to continuing development of healthcare infrastructure is expected to improve the existing hospital amenities worldwide. The home care segment is anticipated to grow at a profitable CAGR during the forecast period, due to the growing geriatric population and increasing need for home care in vitro diagnostic devices.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the market, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations, increasing awareness among patients regarding early diagnosis, and aged population, are the major factors in this region.

Competitor Insights

Some of the key players in the in vitro diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland); Siemens Healthineers (Germany); Danaher Corporation (U.S.); Abbott Laboratories (U.S.); Thermo Fisher Scientific (U.S.); Johnson & Johnson (U.S.); Becton, Dickinson and Company (U.S.); Bio-Rad Laboratories (U.S.); Sysmex Corporation (Japan); and bioMérieux (France). The leading players operating in the in vitro diagnostics industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The in vitro diagnostics market report is categorized into the following segments and subsegments:

In vitro Diagnostics Market, By Product (Revenue, USD Billion, 2021 – 2029)

  • Instruments
  • Reagents
  • Services

In vitro Diagnostics Market, By Technology (Revenue, USD Billion, 2021 – 2029)

  • Immunoassay
    • Instruments
    • Reagents
    • Services
  • Haematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics
    • Instruments
    • Reagents
    • Services
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services

In vitro Diagnostics Market, By Application (Revenue, USD Billion, 2021 – 2029)

  • Oncology
  • Infectious Diseases
  • Nephrology
  • Diabetes
  • Cardiology
  • Autoimmune Diseases
  • Drug Testing
  • Others

In vitro Diagnostics Market, By End User (Revenue, USD Billion, 2021 – 2029)

  • Home Care
  • Laboratory
  • Hospitals
  • Others

In vitro Diagnostics Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of In vitro Diagnostics Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: In-vitro Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: In-vitro Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: In-vitro Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product & Service
    1. Data Management Software
      1. Data Management Software Market Forecast, 2021-2029 (USD Million)
    2. Reagents & Kits
      1. Reagents & Kits Market Forecast, 2021-2029 (USD Million)
    3. Instruments
      1. Instruments Market Forecast, 2021-2029 (USD Million)
    4. Services
      1. Services Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Technology
    1. Coagulation & Haemostasis
      1. Coagulation & Haemostasis Market Forecast, 2021-2029 (USD Million)
    2. Molecular Diagnostics
      1. Molecular Diagnostics Market Forecast, 2021-2029 (USD Million)
    3. Clinical Chemistry
      1. Clinical Chemistry Market Forecast, 2021-2029 (USD Million)
    4. Urinalysis
      1. Urinalysis Market Forecast, 2021-2029 (USD Million)
    5. Microbiology
      1. Microbiology Market Forecast, 2021-2029 (USD Million)
    6. Immunoassay
      1. Immunoassay Market Forecast, 2021-2029 (USD Million)
    7. Haematology
      1. Haematology Market Forecast, 2021-2029 (USD Million)
    8. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application 
    1. Autoimmune Diseases
      1. Autoimmune Diseases Market Forecast, 2021-2029 (USD Million)
    2. Infectious Diseases
      1. Infectious Diseases Market Forecast, 2021-2029 (USD Million)
    3. Cardiology
      1. Cardiology Market Forecast, 2021-2029 (USD Million)
    4. Oncology
      1. Oncology Market Forecast, 2021-2029 (USD Million)
    5. Nephrology
      1. Nephrology Market Forecast, 2021-2029 (USD Million)
    6. Autoimmune Disease
      1. Autoimmune Diseases Market Forecast, 2021-2029 (USD Million)
    7. Drug Testing
      1. Drug Testing Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by End user
    1. Clinical Laboratories
      1. Clinical Laboratories Market Forecast, 2021-2029 (USD Million)
    2. Point-of-care Testing Centres
      1. Point-of-care Testing Centres Market Forecast, 2021-2029 (USD Million)
    3. Academic Institutes
      1. Academic Institutes Market Forecast, 2021-2029 (USD Million)
    4. Hospital Laboratories
      1. Hospital Laboratories Market Forecast, 2021-2029 (USD Million)
    5. Patients
      1. Patients Market Forecast, 2021-2029 (USD Million)
    6. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America In-vitro Diagnostics Market
    1. North America In-vitro Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        4. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. S. In-vitro Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          4. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. Canada In-vitro Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by  Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            4. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Europe In-vitro Diagnostics Market
    1. Europe In-vitro Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        4. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. Germany In-vitro Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          4. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. UK In-vitro Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            4. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. France In-vitro Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
              4. Market Size and Forecast by End user, 2021-2029 (USD Million)
            2. Spain In-vitro Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                4. Market Size and Forecast by End user, 2021-2029 (USD Million)
              2. Italy In-vitro Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  4. Market Size and Forecast by End user, 2021-2029 (USD Million)
                2. Rest of EuropeIn-vitro Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    4. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Asia PacificIn-vitro Diagnostics Market
    1. Asia PacificIn-vitro Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        4. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. Japan In-vitro Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          4. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. China In-vitro Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            4. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. India In-vitro Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
              4. Market Size and Forecast by End user, 2021-2029 (USD Million)
            2. South Korea In-vitro Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                4. Market Size and Forecast by End user, 2021-2029 (USD Million)
              2. Australia In-vitro Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Application 2021-2029 (USD Million)
                  4. Market Size and Forecast by End user, 2021-2029 (USD Million)
                2. Rest of Asia Pacific In-vitro Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    4. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Latin America In-vitro Diagnostics Market
    1. Latin America In-vitro Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        4. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. BrazilIn-vitro Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          4. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. MexicoIn-vitro Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            4. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. Argentina In-vitro Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
              4. Market Size and Forecast by End user, 2021-2029 (USD Million)
            2. Rest of Latin America In-vitro Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast by Application, 2021-2029 (USD Million)
                4. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. MEAIn-vitro Diagnostics Market
    1. MEA In-vitro Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast by Application, 2021-2029 (USD Million)
        4. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. GCC In-vitro Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast by Application, 2021-2029 (USD Million)
          4. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. South Africa In-vitro Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast by Application, 2021-2029 (USD Million)
            4. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. Rest of MEA In-vitro Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast by Application, 2021-2029 (USD Million)
              4. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Roche Diagnostics (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    2. Siemens Healthineers (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    3. Danaher Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    4. Abbott (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    5. Thermo Fisher Scientific (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    6. Johnson & Johnson (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    7. Becton, Dickinson and Company (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    8. Bio-Rad Laboratories (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    9. Sysmex Corporation (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    10. bioMérieux (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    11. DiaSorin (Italy)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    12. Ortho Clinical Diagnostics (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    13. QIAGEN N.V. (Netherlands)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports